Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Odronextamab + Cemiplimab for Aggressive B-Cell Lymphoma
Recruiting2 awardsPhase 1
Santa Monica, California
This trial is studying cemiplimab and REGN1979 to see how well they work in treating patients with lymphoma. The study will last 6-12 months, and participants will be monitored for 6 months after treatment.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service